| Metric | შპს SmartPharm | შპს ფარმაცევტული სახლი + | შპს იმპექსფარმი | შპს ვიტამინი 2017 |
|---|---|---|---|---|
| Growth | ||||
| Revenue | ₾31.6m₾33.9m | ₾61.6m₾65.5m | ₾102.5m₾109.4m | ₾110.9m₾92.7m |
| Revenue growth | -6.8% | -5.8% | -6.4% | 19.6% |
| Profitability | ||||
| EBITDA | ₾3.3m₾4.0m | -₾11.7m | ||
| ₾4.2m₾7.3m |
| ₾6.4m₾2.8m |
| EBITDA margin | 10.4%11.7% | -18.9%-4.1% | 4.1%6.7% | 5.8%3.0% |
| Net profit | ₾2.8m₾4.1m | -₾11.2m-₾3.1m | ₾153k₾10.2m | ₾6.0m₾2.8m |
| Net margin | 8.8%12.1% | -18.2%-4.8% | 0.1%9.3% | 5.4%3.1% |
| Balance sheet | ||||
| Total assets | ₾13.4m₾15.1m | ₾66.5m₾48.9m | ₾91.0m₾86.7m | ₾15.4m₾9.3m |
| Total equity | ₾11.6m₾11.0m | -₾17.3m-₾6.0m | ₾60.1m₾63.2m | ₾12.8m₾8.0m |
| ROE | 23.9%37.0% | — | 0.3%16.1% | 46.7%35.8% |